Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Cardiff Oncology Inc (NASDAQ: CRDF) was $4.54 for the day, down -3.40% from the previous closing price of $4.70. In other words, the price has decreased by -$3.40 from its previous closing price. On the day, 1.18 million shares were traded. CRDF stock price reached its highest trading level at $4.89 during the session, while it also had its lowest trading level at $4.52.
Ratios:
Our analysis of CRDF’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.74 and its Current Ratio is at 4.74. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On December 08, 2021, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $19.Robert W. Baird initiated its Outperform rating on December 08, 2021, with a $19 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 17 ’24 when Levine James E. bought 2,752 shares for $5.42 per share. The transaction valued at 14,905 led to the insider holds 65,316 shares of the business.
Levine James E. bought 2,400 shares of CRDF for $12,000 on Dec 18 ’24. The Chief Financial Officer now owns 67,716 shares after completing the transaction at $5.00 per share. On Dec 16 ’24, another insider, Levine James E., who serves as the Chief Financial Officer of the company, bought 2,564 shares for $3.83 each. As a result, the insider paid 9,820 and bolstered with 62,564 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDF now has a Market Capitalization of 312663456 and an Enterprise Value of 176166208. For the stock, the TTM Price-to-Sale (P/S) ratio is 482.88 while its Price-to-Book (P/B) ratio in mrq is 4.48. Its current Enterprise Value per Revenue stands at 256.056 whereas that against EBITDA is -3.83.
Stock Price History:
Over the past 52 weeks, CRDF has reached a high of $6.42, while it has fallen to a 52-week low of $1.44. The 50-Day Moving Average of the stock is 35.08%, while the 200-Day Moving Average is calculated to be 42.88%.
Shares Statistics:
CRDF traded an average of 2.00M shares per day over the past three months and 1322200 shares per day over the past ten days. A total of 66.52M shares are outstanding, with a floating share count of 61.33M. Insiders hold about 7.80% of the company’s shares, while institutions hold 27.28% stake in the company. Shares short for CRDF as of 1734048000 were 9947769 with a Short Ratio of 4.97, compared to 1731628800 on 7715250. Therefore, it implies a Short% of Shares Outstanding of 9947769 and a Short% of Float of 15.25.
